| Filed On | Filing |
|---|---|
| 30 Oct 2025 |
8-K/A: Regulation FD Disclosure; Other Events
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day |
| 19 Dec 2022 |
8-K/A: Regulation FD Disclosure; Other Events
53% mean exon skipping and <1% (BLQ) mean dystrophin expression six weeks after initiating biweekly multidosing |
| 19 Aug 2020 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 16 Aug 2019 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 17 Aug 2017 | 8-K/A: Submission of Matters to a Vote of Security Holders |
Loading...
